Kevin Murphy
June 2, 2008
A 32 percent plunge in TomoTherapy's stock price in April, after the Madison radiation therapy device maker announced substantially lower first quarter 2008 sales and revenue projections, has prompted an investor to file a class-action lawsuit.
